Xoma | XOMA - Market Capitalization

Stock Price
30.20
Daily Change
0.98 3.35%
Monthly
12.86%
Yearly
42.92%
Q1 Forecast
27.85

Xoma reported $339.7M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 1.66B 1.55B Mar/2026
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Ardelyx USD 1.32B 100M Mar/2026
aTyr Pharma USD 71M 63M Sep/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Celldex Therapeutics USD 1.81B 87M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Incyte USD 19.39B 2.83B Dec/2025
MacroGenics USD 192M 90M Mar/2026
Novartis USD 240.48B 51.73B Mar/2026
Novartis USD 303.66B 40.58B Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
Prothena USD 462M 52M Mar/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025